REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,442,656 | -75.4% | 997,616 | -45.8% | 0.01% | -73.7% |
| Q2 2023 | $46,551,849 | -11.5% | 1,839,267 | +12.6% | 0.04% | -20.8% |
| Q1 2023 | $52,608,757 | +40.7% | 1,633,305 | -19.4% | 0.05% | +26.3% |
| Q4 2022 | $37,400,420 | +29.2% | 2,026,025 | +89.0% | 0.04% | +31.0% |
| Q3 2022 | $28,950,000 | +19.3% | 1,072,235 | -38.9% | 0.03% | +20.8% |
| Q2 2022 | $24,264,000 | -49.0% | 1,755,703 | -28.1% | 0.02% | -31.4% |
| Q1 2022 | $47,605,000 | +32.4% | 2,441,286 | +10.8% | 0.04% | +52.2% |
| Q4 2021 | $35,962,000 | -38.1% | 2,203,564 | +5.7% | 0.02% | -39.5% |
| Q3 2021 | $58,103,000 | +0.9% | 2,085,526 | +7.4% | 0.04% | 0.0% |
| Q2 2021 | $57,578,000 | -1.9% | 1,942,580 | -7.5% | 0.04% | -11.6% |
| Q1 2021 | $58,722,000 | -5.9% | 2,100,983 | -4.6% | 0.04% | -2.3% |
| Q4 2020 | $62,391,000 | +8.6% | 2,201,508 | -3.7% | 0.04% | -4.3% |
| Q3 2020 | $57,471,000 | +10.7% | 2,286,042 | +7.5% | 0.05% | -2.1% |
| Q2 2020 | $51,930,000 | +106.1% | 2,126,541 | +24.9% | 0.05% | +51.6% |
| Q1 2020 | $25,197,000 | +2816.3% | 1,702,524 | +4798.9% | 0.03% | +3000.0% |
| Q3 2018 | $864,000 | -97.2% | 34,753 | -96.9% | 0.00% | -96.7% |
| Q2 2018 | $31,072,000 | -32.0% | 1,131,960 | -23.7% | 0.03% | -33.3% |
| Q1 2018 | $45,678,000 | +49.0% | 1,483,037 | +72.9% | 0.04% | +50.0% |
| Q4 2017 | $30,657,000 | +194.8% | 857,536 | +127.1% | 0.03% | +172.7% |
| Q3 2017 | $10,401,000 | +4.1% | 377,528 | -0.2% | 0.01% | 0.0% |
| Q2 2017 | $9,990,000 | +329.5% | 378,400 | +384.2% | 0.01% | +450.0% |
| Q3 2015 | $2,326,000 | -6.2% | 78,156 | +0.8% | 0.00% | 0.0% |
| Q2 2015 | $2,480,000 | +9.4% | 77,553 | -29.1% | 0.00% | 0.0% |
| Q1 2015 | $2,267,000 | +22.6% | 109,367 | +0.2% | 0.00% | 0.0% |
| Q4 2014 | $1,849,000 | -68.0% | 109,125 | -63.5% | 0.00% | -60.0% |
| Q3 2014 | $5,783,000 | -84.8% | 299,194 | -73.3% | 0.01% | -85.7% |
| Q2 2014 | $38,119,000 | +591.6% | 1,121,134 | +540.8% | 0.04% | +600.0% |
| Q1 2014 | $5,512,000 | – | 174,972 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |